Replies to post #26468 on $heff's $tation of $tocks & $olid DD

[ronpopeil]

I agree with you on POZN $heff. I own a lot of that one too. Don't forget they are working on a third drug that is somewhat of a substitute for aspirin which is suppose to be easier on the stomach. If approved, that could easily be their biggest selling drug. No reason why this company can't have a $1 billion market cap with just Treximet and this new potentially FDA approved drug alone. Imo, they will be bought out, perhaps by Astra Zeneca.

[$heff]

POZN (10.21)…clinical data is extremely strong! Clinical efficacy and safety endpoints have been met per SPA with the FDA